Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × OTHER × Breakthrough Pain × Clear all

Phase

Phase NA 1 Phase 4 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1659 Carcinoma, Non-Small-Cell Lung 1171 Prostatic Neoplasms 884 Colorectal Neoplasms 743 Multiple Myeloma 648 Leukemia, Myeloid, Acute 625 Lung Neoplasms 604 Neoplasms 599 Neoplasm Metastasis 560 Lymphoma 508 Pancreatic Neoplasms 499 Carcinoma, Hepatocellular 495 Stomach Neoplasms 465 Leukemia 453 Recurrence 437 Melanoma 396 Leukemia, Lymphocytic, Chronic, B-Cell 396 Precursor Cell Lymphoblastic Leukemia-Lymphoma 384 Lymphoma, Non-Hodgkin 382 Ovarian Neoplasms 381 Myelodysplastic Syndromes 366 Lymphoma, Large B-Cell, Diffuse 364 Squamous Cell Carcinoma of Head and Neck 363 Brain Neoplasms 360 Head and Neck Neoplasms 355 Rectal Neoplasms 341 Glioblastoma 337 Carcinoma, Renal Cell 301 Hodgkin Disease 297 Esophageal Neoplasms 295

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03809455 2020-04-22

FARADI

UNICANCER

Phase 2 Withdrawn

Breakthrough Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡